Rythmol and Solu-medrol drug interactions - a phase IV clinical study of FDA data

Summary:

Drug interactions are reported among people who take Rythmol (propafenone hydrochloride) and Solu-medrol (methylprednisolone sodium succinate). Common drug interactions include amnesia among females and anaemia among males.

The phase IV clinical study analyzes what interactions people have when they take Rythmol and Solu-medrol. It is created by eHealthMe based on reports of 13 people who take the same drugs from the FDA, and is updated regularly.

What is Rythmol?

Rythmol has active ingredients of propafenone hydrochloride. It is often used in atrial fibrillation/flutter. eHealthMe is studying from 3,638 Rythmol users. Check the latest studies of Rythmol.

What is Solu-medrol?

Solu-medrol has active ingredients of methylprednisolone sodium succinate. It is often used in multiple sclerosis. eHealthMe is studying from 39,410 Solu-medrol users. Check the latest studies of Solu-medrol.



On Aug, 09, 2026

13 people who take Rythmol and Solu-medrol together, and have interactions are studied.

Rythmol and Solu-medrol drug interactions.

What are the common drug interactions of Rythmol and Solu-Medrol, by gender? *:

female:

  1. Amnesia (deficit in memory caused by brain damage, disease, or psychological trauma)
  2. Belligerence (aggressive or warlike behaviour)
  3. Blood creatinine increased
  4. Blood sodium decreased
  5. Convulsion (muscles contract and relax rapidly and repeatedly, resulting in an uncontrolled shaking of the body)
  6. Deep vein thrombosis (blood clot in a major vein that usually develops in the legs and/or pelvis)
  7. Dementia (madness)
  8. Depressed level of consciousness
  9. Drug dependence
  10. Escherichia bacteraemia (presence of bacteria escherichia coli in the blood)

male:

  1. Anaemia (lack of blood)
  2. Hypertension (high blood pressure)
  3. Renal failure acute (rapid kidney dysfunction)
  4. Renal failure chronic (long lasting kidney dysfunction)
  5. Contusion (a type of hematoma of tissue in which capillaries)
  6. Decreased appetite
  7. Muscle spasms (muscle contraction)
  8. Rash erythematous (redness of the skin)
  9. Respiratory failure (inadequate gas exchange by the respiratory system)
  10. Sepsis (a severe blood infection that can lead to organ failure and death)

What are the common drug interactions of Rythmol and Solu-Medrol, by age (0-1 to 60+)? *:

0-1:

  1. Convulsion (muscles contract and relax rapidly and repeatedly, resulting in an uncontrolled shaking of the body)
  2. Deep vein thrombosis (blood clot in a major vein that usually develops in the legs and/or pelvis)
  3. Drug dependence
  4. Pulmonary alveolar haemorrhage (acute bleeding)
  5. Renal failure acute (rapid kidney dysfunction)
  6. Acute respiratory failure

2-9:

n/a

10-19:

n/a

20-29:

n/a

30-39:

n/a

40-49:

n/a

50-59:

  1. Agitation (state of anxiety or nervous excitement)
  2. Amnesia (deficit in memory caused by brain damage, disease, or psychological trauma)
  3. Belligerence (aggressive or warlike behaviour)
  4. Confusional state
  5. Dementia (madness)
  6. Depressed level of consciousness
  7. Hostility
  8. Psychotic disorder
  9. Respiratory depression (respiration has a rate below 12 breaths)

60+:

  1. Anaemia (lack of blood)
  2. Thrombocytopenia (decrease of platelets in blood)
  3. Contusion (a type of hematoma of tissue in which capillaries)
  4. Decreased appetite
  5. Diarrhoea
  6. Diverticulum (out pouching of a hollow (or a fluid-filled) structure in the body)
  7. Leukocytoclastic vasculitis (inflammation of small blood vessels (usually post-capillary venules in the dermis), characterized by palpable purpura)
  8. Lung infection pseudomonal (bacterial infection of lung by pseudomonas aeruginosa)
  9. Renal failure acute (rapid kidney dysfunction)
  10. Renal failure chronic (long lasting kidney dysfunction)

What are the existing conditions these people have? *

  1. Malignant Melanoma (skin cancer rises from melancytes): 2 people, 15.38%
  2. Colitis (inflammation of colon): 2 people, 15.38%
  3. Breast Cancer: 2 people, 15.38%
  4. Systemic Sclerosis (Scleroderma) (an autoimmune or connective tissue disease. it is characterized by thickening of the skin): 1 person, 7.69%
  5. Sick Sinus Syndrome (a collection of heart rhythm disorders): 1 person, 7.69%
  6. Sedation: 1 person, 7.69%
  7. Hypolipidaemia (an abnormally high concentration of fats or lipids in the blood): 1 person, 7.69%
  8. High Blood Pressure: 1 person, 7.69%
  9. Convulsion (muscles contract and relax rapidly and repeatedly, resulting in an uncontrolled shaking of the body): 1 person, 7.69%
  10. Chronic Lymphocytic Leukaemia (cancer in which the bone marrow makes too many lymphocytes (a type of white blood cell)): 1 person, 7.69%

* Approximation only. Some reports may have incomplete information.

Do you take Rythmol and Solu-medrol?

- Personalize this study to your gender, age, symptoms and drugs
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously



Related studies:

Effectiveness of, side effects of, and alternative drugs to the 2 drugs:

Browse all drug interactions of Rythmol and Solu-medrol:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Sub-studies by gender and age:

Female: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Male: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Browse all side effects of Rythmol:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all side effects of Solu-medrol:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all interactions between Rythmol and drugs from A to Z:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all interactions between Solu-medrol and drugs from A to Z:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Related publications that referenced our studies


How the study uses the data?

The study uses data from the FDA. It is based on propafenone hydrochloride and methylprednisolone sodium succinate (the active ingredients of Rythmol and Solu-medrol, respectively), and Rythmol and Solu-medrol (the brand names). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.



Recent studies on eHealthMe: